The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Orchestra BioMed Holdings Inc’s current trading price is -66.80% away from its 52-week high, while its distance from the 52-week low is 2.95%. The stock’s price range for this period has been between $2.37 and $7.35 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.72 million for the day, a number notably higher than the average daily volume of 0.25 million over the last three months.
The present stock price for Orchestra BioMed Holdings Inc (OBIO) is $2.44. In the last trading session, the stock made a considerable jump, reaching $20.0 after an opening price of $2.44. The stock briefly fell to $12.0 before ending the session at $3.06.
Orchestra BioMed Holdings Inc experienced a somewhat shaky performance in the stock market.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Orchestra BioMed Holdings Inc (OBIO) has experienced a quarterly decline of -11.27% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 94.29M and boasts a workforce of 70 employees.
Orchestra BioMed Holdings Inc: What Analysts Are Saying
As of right now, 4 analysts are rating Orchestra BioMed Holdings Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.15, with a change in price of -1.53. Similarly, Orchestra BioMed Holdings Inc recorded 363,321 in trading volume during the last 100 days, posting a change of -38.54%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for OBIO stands at 0.98. Similarly, the long-term debt-to-equity ratio is also 0.94.
OBIO Stock Stochastic Average
Orchestra BioMed Holdings Inc’s raw stochastic average for the past 50 days is presently 0.00%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 0.00%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 47.89% and 54.53%, respectively.
OBIO Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -65.14% this year. Over the last six months, there has been a stronger performance of -56.35%. The price of OBIO leaped by -15.28% during the last 30 days period. For the last 5-days stocks have slided -25.84%.
